Clinical Trial Update: Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial evaluating the combination of conatumumab and panitumumab for metastatic colorectal cancer; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Conatumumab (conatumumab)
• Vectibix (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Colon Cancer, Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-02-06